{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Irvine",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA019952"
        ],
        "brand_name": [
          "HEPARIN SODIUM IN DEXTROSE"
        ],
        "generic_name": [
          "HEPARIN SODIUM AND DEXTROSE"
        ],
        "manufacturer_name": [
          "B. Braun Medical Inc."
        ],
        "product_ndc": [
          "0264-9567",
          "0264-9577",
          "0264-9587"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "HEPARIN SODIUM",
          "DEXTROSE MONOHYDRATE"
        ],
        "rxcui": [
          "1361607",
          "1658717",
          "1659195"
        ],
        "spl_id": [
          "be724659-682a-48b4-bcc0-01be11d8b6e9"
        ],
        "spl_set_id": [
          "92a6f533-1a3d-4734-b413-d245592454e3"
        ],
        "package_ndc": [
          "0264-9567-10",
          "0264-9577-10",
          "0264-9587-20"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "ZZ45AB24CA",
          "LX22YL083G"
        ]
      },
      "product_type": "Drugs",
      "event_id": "92292",
      "recalling_firm": "B. Braun Medical Inc",
      "address_1": "2525 Mcgaw Ave",
      "address_2": "N/A",
      "postal_code": "92614-5841",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0579-2023",
      "product_description": "Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection,  250 ml Excel Container, B. Braun Medical Inc. Bethlehem, PA 18018, USA; API from Spain NDC: 0264-9587-20,",
      "product_quantity": "1,380",
      "reason_for_recall": "Subpotent: Low anti-factor IIa Potency.",
      "recall_initiation_date": "20230509",
      "center_classification_date": "20230516",
      "termination_date": "20240314",
      "report_date": "20230524",
      "code_info": "Lot Number: J1P154N, Exp: 31 May, 2023,"
    }
  ]
}